Sorafenib with Transarterial Chemoembolization Achieves Improved Survival vs. Sorafenib Alone in Advanced Hepatocellular Carcinoma: A Nationwide Population-Based Cohort Study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sorafenib with Transarterial Chemoembolization Achieves Improved Survival vs. Sorafenib Alone in Advanced Hepatocellular Carcinoma: A Nationwide Population-Based Cohort Study
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 7, Pages 985
Publisher
MDPI AG
Online
2019-07-16
DOI
10.3390/cancers11070985
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Real-World Evidence: What It Is and What It Can Tell Us According to the International Society for Pharmacoepidemiology (ISPE) Comparative Effectiveness Research (CER) Special Interest Group (SIG)
- (2018) Hongbo Yuan et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial
- (2018) Joong-Won Park et al. JOURNAL OF HEPATOLOGY
- Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis
- (2017) Janick Weberpals et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Reporting and Guidelines in Propensity Score Analysis: A Systematic Review of Cancer and Cancer Surgical Studies
- (2017) Xiaoxin I. Yao et al. JNCI-Journal of the National Cancer Institute
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Sorafenib improves lipiodol deposition in transarterial chemoembolization of Chinese patients with hepatocellular carcinoma: a long-term, retrospective study
- (2017) Lin Zheng et al. Oncotarget
- Reporting and Guidelines in Propensity Score Analysis: A Systematic Review of Cancer and Cancer Surgical Studies
- (2017) Xiaoxin I. Yao et al. JNCI-Journal of the National Cancer Institute
- Cancer risk in East Asian patients associated with acquired haemolytic anaemia: a nationwide population-based cohort study
- (2016) Victor C. Kok et al. BMC CANCER
- Evaluation of dose-efficacy of sorafenib and effect of transarterial chemoembolization in hepatocellular carcinoma patients: a retrospective study
- (2016) Wang-De Hsiao et al. BMC GASTROENTEROLOGY
- Metformin inhibits the prometastatic effect of sorafenib in hepatocellular carcinoma by upregulating the expression of TIP30
- (2016) Zhigui Guo et al. CANCER SCIENCE
- Combination of metformin and sorafenib suppresses proliferation and induces autophagy of hepatocellular carcinoma via targeting the mTOR pathway
- (2016) Sunbin Ling et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models
- (2016) Abin You et al. Journal of Hematology & Oncology
- Real-World Evidence — What Is It and What Can It Tell Us?
- (2016) Rachel E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON
- (2016) Jean-François Geschwind et al. RADIOLOGY
- The Risks for Ovarian, Endometrial, Breast, Colorectal, and Other Cancers in Women With Newly Diagnosed Endometriosis or Adenomyosis
- (2015) Victor C. Kok et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Open-Label Single-Arm Phase II Trial of Sorafenib Therapy with Drug-eluting Bead Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma: Clinical Results
- (2015) David P. Cosgrove et al. RADIOLOGY
- Use of Transarterial Chemoembolization (TACE) and Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: US Regional Analysis of the GIDEON Registry
- (2015) Jean-Francois H. Geschwind et al. Liver Cancer
- Hypothesis testing for an extended cox model with time-varying coefficients
- (2014) Takumi Saegusa et al. BIOMETRICS
- Population-based cohort study on the risk of malignancy in East Asian children with Juvenile idiopathic arthritis
- (2014) Victor C Kok et al. BMC CANCER
- Association of Nucleos(t)ide Analogue Therapy With Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B—A Nationwide Cohort Study
- (2014) Chun-Ying Wu et al. GASTROENTEROLOGY
- Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Treatment with Transarterial Chemoembolization Combined with Sorafenib—A Retrospective Controlled Study
- (2014) Kangshun Zhu et al. RADIOLOGY
- Sorafenib combined with transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma: a large-scale multicenter study of 222 patients
- (2013) Y. Zhao et al. ANNALS OF ONCOLOGY
- Impact of immortal person-time and time scale in comparative effectiveness research for medical devices: a case for implantable cardioverter-defibrillators
- (2013) Xiaojuan Mi et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Sorafenib in combination with transarterial chemoembolization improves the survival of patients with unresectable hepatocellular carcinoma: A propensity score matching study
- (2013) Wei Bai et al. Journal of Digestive Diseases
- Sorafenib Alone versus Sorafenib Combined with Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: Results of Propensity Score Analyses
- (2013) Gwang Hyeon Choi et al. RADIOLOGY
- The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma
- (2011) R. Cabrera et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Increased Risk of Ischemic Stroke in Young Nasopharyngeal Carcinoma Patients
- (2011) Ching-Chih Lee et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma
- (2011) Timothy M. Pawlik et al. JOURNAL OF CLINICAL ONCOLOGY
- Periprocedural complications by Child-Pugh class in patients undergoing transcatheter arterial embolization or chemoembolization to treat unresectable hepatocellular carcinoma at a VA medical center
- (2010) Jeffery S. Russell et al. AMERICAN JOURNAL OF SURGERY
- Continuous Administration of Sorafenib in Combination with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: Results of a Phase I Study
- (2010) J.-F. Dufour et al. ONCOLOGIST
- Transcatheter Arterial Chemoembolization (TACE) in Hepatocellular Carcinoma (HCC): The Role of Angiogenesis and Invasiveness
- (2008) Adriana Sergio et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patients
- (2008) Ju Hyun Shim et al. CANCER SCIENCE
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started